Daisuke Nishizaki, MD (@zacksurg) 's Twitter Profile
Daisuke Nishizaki, MD

@zacksurg

Surgical oncologist / Clinical research, precision medicine, data visualization, minimally invasive surgery / Tweets are my own

ID: 1168522210832551936

calendar_today02-09-2019 13:53:21

22 Tweet

18 Followers

41 Following

Daisuke Nishizaki, MD (@zacksurg) 's Twitter Profile Photo

Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis jclinepi.com/article/0895-4…

Daisuke Nishizaki, MD (@zacksurg) 's Twitter Profile Photo

The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI) ejso.com/article/S0748-…

Cochrane (@cochranecollab) 's Twitter Profile Photo

"With the deepest disappointment and regret I have to inform you that as a result of the continued spread and impact of the COVID-19 across the world, Cochrane’s 27th Colloquium in Toronto, Canada, between 4th-7th October this year has been cancelled." buff.ly/3c6hoNi

Daisuke Nishizaki, MD (@zacksurg) 's Twitter Profile Photo

HR is the mainstream, but RMST is easy to interpret. Would it be a new standard? Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Car… pubmed.ncbi.nlm.nih.gov/31634007/

JCOG (@jcog_official) 's Twitter Profile Photo

🆕JCOG0603 "Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial" was published in JCO! ascopubs.org/doi/abs/10.120… #ColorectalCancer #JCO ASCO ASCO Publications #JCOG

🆕JCOG0603
"Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial" was published in JCO!

ascopubs.org/doi/abs/10.120…

#ColorectalCancer #JCO <a href="/ASCO/">ASCO</a> <a href="/ASCO_pubs/">ASCO Publications</a> #JCOG
Cochrane (@cochranecollab) 's Twitter Profile Photo

It is with considerable regret that Cochrane's Governing Board announces the cancellation of Cochrane Colloquium Toronto which had been rescheduled for 11-14th September, 2022. buff.ly/3hsHIpC Cochrane Canada

Yu Fujiwara, MD (@waraonc23) 's Twitter Profile Photo

ASCO abstract titles released! See you all in AM on June 3rd at the Poster hall McCormick Place in Chicago #ASCO23 I'll present our work (#2614) on associations of IDO1 with immune markers as well as it's impact on survival of immune checkpoint inhibitors. #PrecisionMedicine

<a href="/ASCO/">ASCO</a> abstract titles released! See you all in AM on June 3rd at the Poster hall <a href="/McCormick_Place/">McCormick Place</a> in Chicago #ASCO23 I'll present our work (#2614) on associations of IDO1 with immune markers as well as it's impact on survival of immune checkpoint inhibitors. #PrecisionMedicine
Yu Fujiwara, MD (@waraonc23) 's Twitter Profile Photo

Good morning! Excited to present our research progress focusing on B- and T-cell factors and their response to immunotherapy. Poster #105 at Hall A from 9AM to noon today. Roswell Park Hematology/Oncology Fellowship Daisuke Nishizaki, MD Hirotaka Miyashita, MD Labcorp OmniSeq Razelle Kurzrock, MD #ASCO24 ascopubs.org/doi/10.1200/JC…